ClinicalTrials.govpublic full text
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
parkinson's disease, safinamide - parkinson's disease - levodopa induced dyskinesia, advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia., interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874759
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.